Adial Pharmaceuticals' Unattributed - III Round

Adial Pharmaceuticals raised a round of funding on June 14, 2018.

Adial Pharmaceuticals is focused on developing effective medications to treat addiction and related disorders. The company's most advanced compound AD04 specifically targets Alcohol Use Disorder throu…

Articles about Adial Pharmaceuticals' Unattributed - III Round: